Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma Manifesting as a Scalp Hematoma After an Acute Head Injury-a Case Report and Literature Review

World Neurosurg. 2016 Apr:88:688.e13-688.e16. doi: 10.1016/j.wneu.2015.11.020. Epub 2015 Nov 23.

Abstract

Background: Anaplastic large cell lymphoma (ALCL) is a malignant non-Hodgkin lymphoma, typically associated with anaplastic lymphoma kinase (ALK) expression. In some cases, lack of ALK translocation correlated with a more unfavorable prognosis.

Case description: We describe a case of ALK(-) ALCL that manifested as a progressive, enlarged, swollen mass on the scalp after an acute head injury in an 84-year-old man. Neither palpable lymph nodes nor any B symptoms were noted on admission. Brain computed tomography showed a hematoma in the right posterior occipital region of the scalp as the only remarkable finding. Débridement and biopsy were performed. Histologic and immunohistochemical analysis of the specimen revealed an ALK(-) ALCL of the scalp. The lymphoma was resistant to bendamustine-containing chemotherapies, ultimately leading to the patient's death within 2 months.

Conclusions: This case report highlights the importance of recognizing the possibility of an ALCL manifesting as a focal inflammatory swelling mass on the scalp.

Keywords: Anaplastic large cell lymphoma (ALCL); Anaplastic lymphoma kinase (ALK); Head injury; Scalp hematoma.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged, 80 and over
  • Anaplastic Lymphoma Kinase
  • Diagnosis, Differential
  • Fatal Outcome
  • Head and Neck Neoplasms / complications*
  • Head and Neck Neoplasms / diagnosis
  • Head and Neck Neoplasms / drug therapy
  • Hematoma / etiology*
  • Humans
  • Lymphoma, Large-Cell, Anaplastic / complications*
  • Lymphoma, Large-Cell, Anaplastic / diagnosis*
  • Lymphoma, Large-Cell, Anaplastic / drug therapy
  • Male
  • Receptor Protein-Tyrosine Kinases / metabolism
  • Scalp / pathology*
  • Skin Neoplasms / complications*
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / drug therapy
  • Treatment Failure

Substances

  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Receptor Protein-Tyrosine Kinases